
imaware is a health technology company that provides a comprehensive diagnostics platform and personalized biomarker testing solutions. Their platform offers over 200 biomarkers covering a wide range of health conditions, enabling businesses, healthcare providers, and consumers to access advanced diagnostics through at-home or lab-based testing. The company supports white-label solutions, customizable branding, and seamless integrations with healthcare systems, emphasizing clinical validity, HIPAA-compliant data security, and medical oversight. imaware has evolved from a direct-to-consumer testing company to a leading B2B diagnostics platform provider, serving diverse healthcare ecosystem needs including wellness companies, employers, pharmaceuticals, health systems, and payors. Their platform facilitates personalized health data delivery, virtual care, and recurring testing, positioning them as a scalable and innovative player in personalized health management and wellness.

imaware is a health technology company that provides a comprehensive diagnostics platform and personalized biomarker testing solutions. Their platform offers over 200 biomarkers covering a wide range of health conditions, enabling businesses, healthcare providers, and consumers to access advanced diagnostics through at-home or lab-based testing. The company supports white-label solutions, customizable branding, and seamless integrations with healthcare systems, emphasizing clinical validity, HIPAA-compliant data security, and medical oversight. imaware has evolved from a direct-to-consumer testing company to a leading B2B diagnostics platform provider, serving diverse healthcare ecosystem needs including wellness companies, employers, pharmaceuticals, health systems, and payors. Their platform facilitates personalized health data delivery, virtual care, and recurring testing, positioning them as a scalable and innovative player in personalized health management and wellness.
What they do: Digital health diagnostics platform offering 200+ biomarkers, at-home and lab testing, and white-label solutions
Customers: Enterprises including employers, payors, providers, and consumer brands
Scale: Reports serving millions of patients (company statements)
Recent M&A: Acquired binx health's consumer at‑home testing business (Dec 2023)
Funding signal: Convertible note closed Jan 9, 2023; lead investor listed as Trinity Biotech
Personalized diagnostics, preventive health, and enterprise-grade at‑home testing integrations.
Digital health; diagnostics
Most recently reported round per company funding records
“Trinity Biotech listed as lead investor on the Jan 9, 2023 convertible note”